Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A 1 adenosine receptor agonists

A series of purine ribonucleosides bearing chiral amino acid amides at the C6 position of 2-chloropurine was synthesized. Molecular docking of the synthesized analogs of 2-chloroadenosine by their affinity for A adenosine receptors (A ARs) was conducted. The investigation of A AR stimulating activit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic chemistry 2022-05, Vol.126, p.105878
Hauptverfasser: Berzina, Maria Ya, Eletskaya, Barbara Z, Kayushin, Alexei L, Dorofeeva, Elena V, Lutonina, Olga I, Fateev, Ilya V, Paramonov, Alexander S, Kostromina, Maria A, Zayats, Evgeniy A, Abramchik, Yulia A, Maltsev, Dmitriy V, Naumenko, Ludmila V, Taran, Alena S, Yakovlev, Dmitry S, Spasov, Alexander A, Miroshnikov, Anatoly I, Esipov, Roman S, Konstantinova, Irina D
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A series of purine ribonucleosides bearing chiral amino acid amides at the C6 position of 2-chloropurine was synthesized. Molecular docking of the synthesized analogs of 2-chloroadenosine by their affinity for A adenosine receptors (A ARs) was conducted. The investigation of A AR stimulating activity of synthesized nucleosides was carried out in a model of an isolated mouse atrium. We have shown that derivatives with tyrosine, valine, and serine residues exhibit the properties of A AR partial agonists. Animal experiments in the open field test have shown that these compounds have different profiles of psychoactive action. These nucleosides have an ophthalmic hypotensive effect and reduce intraocular pressure in a manner slightly inferior to that of timolol and brimonidine. The synthesized nucleosides can be the basis for further design and synthesis of new A AR agonists.
ISSN:1090-2120
DOI:10.1016/j.bioorg.2022.105878